Veratric acid inhibits iNOS expression through the regulation of PI3K activation and histone acetylation in LPS-stimulated RAW264.7 cells

International Journal of Molecular Medicine

Volumn 35, Issue 1, 2015, Pages 202-210

  Choi, Woo Suk ^a   Seo, Yong Bae ^a   Shin, Pyung Gyun ^b   Kim, Woe Yeon ^c   Lee, Sang Yeol ^c   Choi, Young Ju ^d   Kim, Gun Do ^a  

^a Pukyong National University   (South Korea)

^b Rural Development Administration   (South Korea)

^c Gyeongsang National University   (South Korea)

^d Silla University   (South Korea)

Author keywords

Histone; Histone acetyltransferases; Histone deacetylases; Inducible nitric oxide synthase; Phosphoinositide 3 kinase Akt; Veratric acid

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ACTIVATING TRANSCRIPTION FACTOR 2; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; E1A ASSOCIATED P300 PROTEIN; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE H3; HISTONE H4; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B; PROTEIN P110; PROTEIN P110 ALPHA; PROTEIN P110 BETA; PROTEIN P85; UNCLASSIFIED DRUG; VERATRIC ACID; HISTONE DEACETYLASE; VANILLIC ACID;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DERMATITIS; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; HISTONE ACETYLATION; INFLAMMATORY CELL; METABOLIC REGULATION; MOUSE; NONHUMAN; PROTEIN ACETYLATION; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOPICAL TREATMENT; WESTERN BLOTTING; ACETYLATION; ANALOGS AND DERIVATIVES; ANIMAL; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MACROPHAGE; METABOLISM;

ACETYLATION; ANIMALS; CELL LINE; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; HISTONES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; VANILLIC ACID;

EID: 84917744288     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1982     Document Type: Article

References (46)

1. Swantek JL, Christerson L and Cobb MH: Lipopolysaccharide-induced tumor necrosis factor-α promoter activity is inhibitor of nuclear factor-κB kinase-dependent. J Biol Chem 274: 11667-11671, 1999.
2. Sharma J, Al-Omran A and Parvathy S: Role of nitric oxide in inflammatory diseases. Inflammopharmacology 15: 252-259, 2007.
3. Bogdan C: Nitric oxide and the immune response. Nat Immunol 2: 907-916, 2001.
4. Bogdan C, Röllinghoff M and Diefenbach A: The role of nitric oxide in innate immunity. Immunol Rev 173: 17-26, 2000.
5. Zamora R, Vodovotz Y and Billiar TR: Inducible nitric oxide synthase and inflammatory diseases. Mol Med 6: 347-373, 2000.
6. Sakai K, Suzuki H, Oda H, et al: Phosphoinositide 3-kinase in nitric oxide synthesis in macrophage: critical dimerization of inducible nitric-oxide synthase. J Biol Chem 281: 17736-17742, 2006.
7. Luyendyk JP, Schabbauer GA, Tencati M, Holscher T, Pawlinski R and Mackman N: Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages. J Immunol 180: 4218-4226, 2008.
8. Pahan K, Raymond JR and Singh I: Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide-or cytokine-stimulated C6 glial cells. J Biol Chem 274: 7528-7536, 1999.
9. Pahan K, Liu X, Wood C and Raymond JR: Expression of a constitutively active form of phosphatidylinositol 3-kinase inhibits the induction of nitric oxide synthase in human astrocytes. FEBS Lett 472: 203-207, 2000.
10. Teshima S, Nakanishi H, Nishizawa M, et al: Up-regulation of IL-1 receptor through PI3K/Akt is essential for the induction of iNOS gene expression in hepatocytes. J Hepatol 40: 616-623, 2004.
11. Choudhary C, Kumar C, Gnad F, et al: Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325: 834-840, 2009.
12. Ghizzoni M, Haisma HJ, Maarsingh H and Dekker FJ: Histone acetyltransferases are crucial regulators in NF-κB mediated inflammation. Drug Discov Today 16: 504-511, 2011.
13. Yang WM, Tsai SC, Wen YD, Fejér G and Seto E: Functional domains of histone deacetylase-3. J Biol Chem 277: 9447-9454, 2002.
14. Roth SY, Denu JM and Allis CD: Histone acetyltransferases. Annu Rev Biochem 70: 81-120, 2001.
15. Lin HY, Chen CS, Lin SP, Weng JR and Chen CS: Targeting histone deacetylase in cancer therapy. Med Res Rev 26: 397-413, 2006.
16. Raja B: Veratric acid, a phenolic acid attenuates blood pressure and oxidative stress in l-NAME induced hypertensive rats. Eur J Pharmacol 671: 87-94, 2011.
17. Kim MY, Seguin P, Ahn JK, et al: Phenolic compound concentration and antioxidant activities of edible and medicinal mushrooms from Korea. J Agr Food Chem 56: 7265-7270, 2008.
18. Choi WS, Shin PG, Lee JH and Kim GD: The regulatory effect of veratric acid on NO production in LPS-stimulated RAW264. 7 macrophage cells. Cell Immunol 280: 164-170, 2012.
19. Stiehl DP, Fath DM, Liang D, Jiang Y and Sang N: Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation. Cancer Res 67: 2256-2264, 2007.
20. Huang WC and Chen CC: Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity. Mol Cell Biol 25: 6592-6602, 2005.
21. Takasawa S, Ikeda T, Akiyama T, et al: Cyclin D1 activation through ATF-2 in Reg-induced pancreatic β-cell regeneration. FEBS Lett 580: 585-591, 2006.
22. Kawasaki H, Schiltz L, Chiu R, et al: ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation. Nature 405: 195-200, 2000.
23. Miao F, Gonzalo IG, Lanting L and Natarajan R: In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 279: 18091-18097, 2004.
24. Geering B, Cutillas PR, Nock G, Gharbi SI and Vanhaesebroeck B: Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers. Proc Natl Acad Sci USA 104: 7809-7814, 2007.
25. Koyasu S: The role of PI3K in immune cells. Nat Immunol 4: 313-319, 2003.
26. Monick MM, Carter AB, Robeff PK, Flaherty DM, Peterson MW and Hunninghake GW: Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of β-catenin. J Immunol 166: 4713-4720, 2001.
27. Tsukamoto K, Hazeki K, Hoshi M, et al: Critical roles of the p110β subtype of phosphoinositide 3-kinase in lipopolysaccharide-induced Akt activation and negative regulation of nitrite production in RAW 264.7 cells. J Immunol 180: 2054-2061, 2008.
28. Sheu ML, Chao KF, Sung YJ, Lin WW, Lin-Shiau SY and Liu SH: Activation of phosphoinositide 3-kinase in response to inflammation and nitric oxide leads to the up-regulation of cyclooxygenase-2 expression and subsequent cell proliferation in mesangial cells. Cell Signal 17: 975-984, 2005.
29. Chiou WF, Don MJ, Liao JF and Wei BL: Psoralidin inhibits LPS-induced iNOS expression via repressing Syk-mediated activation of PI3K-IKK-IκB signaling pathways. Eur J Pharmacol 650: 102-109, 2011.
30. Chen J, Halappanavar S, St-Germain J, Tsang B and Li Q: Role of Akt/protein kinase B in the activity of transcriptional coactivator p300. Cell Mol Life Sci 61: 1675-1683, 2004.
31. Liu Y, Denlinger CE, Rundall BK, Smith PW and Jones DR: Suberoylanilide hydroxamic acid induces Akt-mediated phosphorylation of p300, which promotes acetylation and transcriptional activation of RelA/p65. J Biol Chem 281: 31359-31368, 2006.
32. Deng WG and Wu KK: Regulation of inducible nitric oxide synthase expression by p300 and p50 acetylation. J Immunol 171: 6581-6588, 2003.
33. Bruhat A, Chérasse Y, Maurin AC, et al: ATF2 is required for amino acid-regulated transcription by orchestrating specific histone acetylation. Nucleic Acid Res 35: 1312-1321, 2007.
34. Chang PC, Chen TH, Chang CJ, Hou CC, Chan P and Lee HM: Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway. Kidney Int 65: 1664-1675, 2004.
35. Lundh M, Christensen D, Nielsen MD, et al: Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children. Diabetologia 55: 2421-2431, 2012.
36. Chen LF, Fischle W, Verdin E and Greene WC: Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293: 1653-1657, 2001.
37. Yu Z, Zhang W and Kone BC: Histone deacetylases augment cytokine induction of the iNOS gene. J Am Soc Nephrol 13: 2009-2017, 2002.
38. Ashburner BP, Westerheide SD and Baldwin AS: The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21: 7065-7077, 2001.
39. Barter MJ, Pybus L, Litherland GJ, et al: HDAC-mediated control of ERK-and PI3K-dependent TGF-β-induced extracellular matrix-regulating genes. Matrix Biol 29: 602-612, 2010.
40. Lv WW, Wei HM, Wang DL, Ni JQ and Sun FL: Depletion of histone deacetylase 3 antagonizes PI3K-mediated overgrowth of Drosophila organs through the acetylation of histone H4 at lysine 16. J Cell Sci 125: 5369-5378, 2012.
41. Hargreaves DC, Horng T and Medzhitov R: Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 138: 129-145, 2009.
42. Modak R, Mitra SD, Krishnamoorthy P, et al: Histone H3K14 and H4K8 hyperacetylation is associated with Escherichia coli-induced mastitis in mice. Epigenetics 7: 492-501, 2012.
43. Tsaprouni LG, Ito K, Powell JJ, Adcock IM and Punchard N: Differential patterns of histone acetylation in inflammatory bowel diseases. J Inflamm 8: 1, 2011.
44. Ito K, Barnes PJ and Adcock IM: Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1β-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 20: 6891-6903, 2000.
45. Lowenstein CJ, Alley EW, Raval P, et al: Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA 90: 9730-9734, 1993.
46. Yu Z and Kone BC: Targeted histone H4 acetylation via phosphoinositide 3-kinase-and p70s6-kinase-dependent pathways inhibits iNOS induction in mesangial cells. Am J Physiol Renal Physiol 290: F496-F502, 2006.